Ausgabe 1/2017
Inhalt (21 Artikel)
Breast cancer risk and clinical implications for germline PTEN mutation carriers
Joanne Ngeow, Kaitlin Sesock, Charis Eng
Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis
Melissa J. Edwards, Ian D. Campbell, Ross A. Lawrenson, Marion J. Kuper-Hommel
Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model
Chiaming Fan, Kristen R. Georgiou, Howard A. Morris, Ross A. McKinnon, Dorothy M. K. Keefe, Peter R. Howe, Cory J. Xian
Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer
Michael J. Flister, Shirng-Wern Tsaih, Alexander Stoddard, Cody Plasterer, Jaidip Jagtap, Abdul K. Parchur, Gayatri Sharma, Anthony R. Prisco, Angela Lemke, Dana Murphy, Mona Al-Gizawiy, Michael Straza, Sophia Ran, Aron M. Geurts, Melinda R. Dwinell, Andrew S. Greene, Carmen Bergom, Peter S. LaViolette, Amit Joshi
The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis
Gulisa Turashvili, Edi Brogi, Monica Morrow, Clifford Hudis, Maura Dickler, Larry Norton, Hannah Y. Wen
Sexual health needs and educational intervention preferences for women with cancer
Cara Stabile, Shari Goldfarb, Raymond E. Baser, Deborah J. Goldfrank, Nadeem R. Abu-Rustum, Richard R. Barakat, Maura N. Dickler, Jeanne Carter
Primary tumor location predicts the site of local relapse after nipple–areola complex (NAC) sparing mastectomy
Nicoletta Tomasi Cont, Furio Maggiorotto, Laura Martincich, Alessandro Rivolin, Franziska Kubatzki, Paola Sgandurra, Francesco Marocco, Alessandra Magistris, Marco Gatti, Davide Balmativola, Filippo Montemurro, Anna Sapino, Riccardo Ponzone
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
Cynthia A. Thomson, H. H. Sherry Chow, Betsy C. Wertheim, Denise J. Roe, Alison Stopeck, Gertraud Maskarinec, Maria Altbach, Pavani Chalasani, Chuan Huang, Meghan B. Strom, Jean-Philippe Galons, Patricia A. Thompson
Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery
Tae-Kyung Yoo, Byung Joo Chae, Sei Joong Kim, JungSun Lee, Tae In Yoon, Soo Jung Lee, Ho Yong Park, Heung Kyu Park, Yong Hwa Eom, Hyung Suk Kim, Chang Jong Kim, Man sik Shin, Sun Hyong You, Byung Joo Song
Unenhanced magnetic resonance screening using fused diffusion-weighted imaging and maximum-intensity projection in patients with a personal history of breast cancer: role of fused DWI for postoperative screening
Ji Won Kang, Hee Jung Shin, Ki Chang Shin, Eun Young Chae, Woo Jung Choi, Joo Hee Cha, Hak Hee Kim
Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657)
Neelima Vidula, Christina Yau, Jiali Li, Laura J. Esserman, Hope S. Rugo
First international consensus conference on standardization of oncoplastic breast conserving surgery
Walter P. Weber, Savas D. Soysal, Mahmoud El-Tamer, Virgilio Sacchini, Michael Knauer, Christoph Tausch, Nik Hauser, Andreas Günthert, Yves Harder, Elisabeth A. Kappos, Fabienne Schwab, Florian Fitzal, Peter Dubsky, Vesna Bjelic-Radisic, Roland Reitsamer, Rupert Koller, Jörg Heil, Markus Hahn, Jens-Uwe Blohmer, Jürgen Hoffmann, Christine Solbach, Christoph Heitmann, Bernd Gerber, Martin Haug, Christian Kurzeder
Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy
A. Jo Chien, Julia Chambers, Fiona Mcauley, Tessa Kaplan, Joseph Letourneau, Jimmy Hwang, Mi-Ok Kim, Michelle E. Melisko, Hope S. Rugo, Laura J. Esserman, Mitchell P. Rosen
Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy
A. Jo Chien, Julia Chambers, Fiona Mcauley, Tessa Kaplan, Joseph Letourneau, Jimmy Hwang, Mi-Ok Kim, Michelle E. Melisko, Hope S. Rugo, Laura J. Esserman, Mitchell P. Rosen
Influence of clinical, societal, and treatment variables on racial differences in ER−/PR− breast cancer survival
M. E. Roseland, K. Schwartz, J. J. Ruterbusch, L. Lamerato, R. Krajenta, J. Booza, Michael S. Simon
Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer
Devika R. Jutagir, Bonnie B. Blomberg, Charles S. Carver, Suzanne C. Lechner, Kiara R. Timpano, Laura C. Bouchard, Lisa M. Gudenkauf, Jamie M. Jacobs, Alain Diaz, Susan K. Lutgendorf, Steve W. Cole, Aaron S. Heller, Michael H. Antoni
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Jeffrey I. Campbell, Christina Yau, Polina Krass, Dan Moore, Lisa A. Carey, Alfred Au, David Chhieng, Dilip Giri, Chad Livasy, Carolyn Mies, Joseph Rabban, Venetia R. Sarode, Baljit Singh, Laura Esserman, Yunn-Yi Chen
Family history and risk of breast cancer: an analysis accounting for family structure
Hannah R. Brewer, Michael E. Jones, Minouk J. Schoemaker, Alan Ashworth, Anthony J. Swerdlow
Lifetime moderate-to-vigorous physical activity and ER/PR/HER-defined post-menopausal breast cancer risk
Joy Shi, Lindsay C. Kobayashi, Anne Grundy, Harriet Richardson, Sandip K. SenGupta, Caroline A. Lohrisch, John J. Spinelli, Kristan J. Aronson
Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk
Robert J. Glynn, Graham A. Colditz, Rulla M. Tamimi, Wendy Y. Chen, Susan E. Hankinson, Walter W. Willett, Bernard Rosner